T-Cell and B-Cell Targeting Agents in Rheumatoid Arthritis

Article

In a Cleveland Clinic video, William Rigby, MD, of Dartmouth Medical School, discusses B-cell and T-cell-directed therapy for rheumatoid arthritis.

In this video from the Cleveland Clinic, William Rigby, MD, professor and vice-chair of medicine at Dartmouth Medical School, discusses B-cell and T-cell-directed therapy for rheumatoid arthritis.

Related Videos
Emilie Aschenbrenner, PharmD, BCOP, a hematology coordinator for pharmacy at Froedtert and the Medical College of Wisconsin
Raj Chovatiya, MD, PhD
Jessica S. Little, MD, a transplant infectious diseases physician at Dana-Farber Cancer Institute
Nirav N. Shah, MD
Alexis Kuhn, PharmD, BCOP, a pediatric oncology pharmacist at the Mayo Clinic
Haydar Frangoul, MD
Aimee C. Talleur, MD, a physician at St. Jude Children’s Research Hospital
Pat Furlong, BSN, RN
© 2024 MJH Life Sciences

All rights reserved.